Literature DB >> 22130703

Clot retraction.

Katherine L Tucker1, Tanya Sage, Jonathan M Gibbins.   

Abstract

The study of clot retraction in vitro has been adopted as a simple and reproducible approach to assess platelet function. Plasma clots should retract away from the sides of a glass tube within a few hours allowing the rapid characterization of outside-in signaling through platelet integrin α(IIb)β(3). In this chapter, we describe the role of platelets in fibrin clot retraction and provide a detailed description of the methods used to assess this process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22130703      PMCID: PMC6446996          DOI: 10.1007/978-1-61779-307-3_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Regulation of clot retraction by glycoprotein IIb/IIIa antagonists.

Authors:  Dietmar Seiffert; Donna L Pedicord; Cathy J Kieras; Bokang He; Andrew M Stern; Jeffrey T Billheimer
Journal:  Thromb Res       Date:  2002-11-01       Impact factor: 3.944

Review 2.  The role of collagen in thrombosis and hemostasis.

Authors:  R W Farndale; J J Sixma; M J Barnes; P G de Groot
Journal:  J Thromb Haemost       Date:  2004-04       Impact factor: 5.824

3.  mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets.

Authors:  Andrew S Weyrich; Melvin M Denis; Hansjorg Schwertz; Neal D Tolley; Jason Foulks; Eliott Spencer; Larry W Kraiss; Kurt H Albertine; Thomas M McIntyre; Guy A Zimmerman
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

4.  Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function.

Authors:  D A Law; F R DeGuzman; P Heiser; K Ministri-Madrid; N Killeen; D R Phillips
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

Review 5.  Thrombin signalling and protease-activated receptors.

Authors:  S R Coughlin
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

6.  AMPK α2 subunit is involved in platelet signaling, clot retraction, and thrombus stability.

Authors:  Voahanginirina Randriamboavonjy; Johann Isaak; Timo Frömel; Benoit Viollet; Beate Fisslthaler; Klaus T Preissner; Ingrid Fleming
Journal:  Blood       Date:  2010-06-17       Impact factor: 22.113

7.  Tyrosine phosphorylation of the Fc receptor gamma-chain in collagen-stimulated platelets.

Authors:  J Gibbins; J Asselin; R Farndale; M Barnes; C L Law; S P Watson
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

Review 8.  Integrins: dynamic scaffolds for adhesion and signaling in platelets.

Authors:  Sanford J Shattil; Peter J Newman
Journal:  Blood       Date:  2004-06-17       Impact factor: 22.113

Review 9.  Signaling events underlying thrombus formation.

Authors:  S P Jackson; W S Nesbitt; S Kulkarni
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

10.  Tyrosine kinases regulate the cytoskeletal attachment of integrin alpha IIb beta 3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin polymers.

Authors:  S M Schoenwaelder; S P Jackson; Y Yuan; M S Teasdale; H H Salem; C A Mitchell
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

View more
  12 in total

1.  Fibrin-Based Biomaterial Systems to Enhance Anterior Cruciate Ligament Healing.

Authors:  Grant Scull; Matthew B Fisher; Ashley C Brown
Journal:  Med Devices Sens       Date:  2020-11-11

2.  Carbamylation of Integrin α IIb β 3: The Mechanistic Link to Platelet Dysfunction in ESKD.

Authors:  Veronika Binder; Barbara Chruścicka-Smaga; Brith Bergum; Stéphane Jaisson; Philippe Gillery; Joar Sivertsen; Tor Hervig; Marta Kaminska; Ronak Tilvawala; Venkatesh V Nemmara; Paul R Thompson; Jan Potempa; Hans-Peter Marti; Piotr Mydel
Journal:  J Am Soc Nephrol       Date:  2022-08-29       Impact factor: 14.978

3.  Trpc6 gain-of-function disease mutation enhances phosphatidylserine exposure in murine platelets.

Authors:  Kimber L Boekell; Brittney J Brown; Brianna E Talbot; Johannes S Schlondorff
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

4.  Heterozygous mutation SLFN14 K208N in mice mediates species-specific differences in platelet and erythroid lineage commitment.

Authors:  Rachel J Stapley; Christopher W Smith; Elizabeth J Haining; Andrea Bacon; Sian Lax; Vera P Pisareva; Andrey V Pisarev; Steve P Watson; Abdullah O Khan; Neil V Morgan
Journal:  Blood Adv       Date:  2021-01-26

5.  Mice lacking the SLAM family member CD84 display unaltered platelet function in hemostasis and thrombosis.

Authors:  Sebastian Hofmann; Attila Braun; Rastislav Pozgaj; Martina Morowski; Timo Vögtle; Bernhard Nieswandt
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

6.  A Novel αIIbβ3 Antagonist from Snake Venom Prevents Thrombosis without Causing Bleeding.

Authors:  Yu-Ju Kuo; Ching-Hu Chung; Tzu-Yu Pan; Woei-Jer Chuang; Tur-Fu Huang
Journal:  Toxins (Basel)       Date:  2019-12-21       Impact factor: 4.546

7.  Effects of Nanoceria on Human Platelet Functions and Blood Coagulation.

Authors:  Jyotsna Kailashiya; Debabrata Dash
Journal:  Int J Nanomedicine       Date:  2022-01-20

8.  Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction.

Authors:  María Luisa Lozano; Aaron Cook; José María Bastida; David S Paul; Gemma Iruin; Ana Rosa Cid; Rosa Adan-Pedroso; José Ramón González-Porras; Jesús María Hernández-Rivas; Sarah J Fletcher; Ben Johnson; Neil Morgan; Francisca Ferrer-Marin; Vicente Vicente; John Sondek; Steve P Watson; Wolfgang Bergmeier; José Rivera
Journal:  Blood       Date:  2016-05-27       Impact factor: 22.113

9.  Syncytiotrophoblast Extracellular Vesicles from Pre-Eclampsia Placentas Differentially Affect Platelet Function.

Authors:  Dionne S Tannetta; Kathryn Hunt; Chris I Jones; Naomi Davidson; Carmen H Coxon; David Ferguson; Christopher W Redman; Jonathan M Gibbins; Ian L Sargent; Katherine L Tucker
Journal:  PLoS One       Date:  2015-11-09       Impact factor: 3.240

10.  Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis.

Authors:  Brian D Adair; José L Alonso; Johannes van Agthoven; Vincent Hayes; Hyun Sook Ahn; I-Shing Yu; Shu-Wha Lin; Jian-Ping Xiong; Mortimer Poncz; M Amin Arnaout
Journal:  Nat Commun       Date:  2020-01-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.